In the last trading session, 1.4 million PDS Biotechnology Corporation (NASDAQ:PDSB) shares changed hands as the company’s beta touched 1.28. With the company’s per share price at $1.63 changed hands at $0.17 or 11.64% during last session, the market valuation stood at $74.51M. PDSB’s last price was a discount, traded about -171.17% off its 52-week high of $4.42. The share price had its 52-week low at $0.85, which suggests the last value was 47.85% up since then.
Analysts gave the PDS Biotechnology Corporation (PDSB) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended PDSB as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
PDS Biotechnology Corporation (NASDAQ:PDSB) trade information
Instantly PDSB was in green as seen at the end of in last trading. With action 28.35%, the performance over the past five days has been green. However, in the 30-day time frame, PDS Biotechnology Corporation (NASDAQ:PDSB) is 50.93% up.
The consensus price target for the stock as assigned by Wall Street analysts is 9, meaning bulls need an upside of 81.89% from its current market value. According to analyst projections, PDSB’s forecast low is 9 with 9 as the target high. To hit the forecast high, the stock’s price needs a -452.15% plunge from its current level, while the stock would need to soar -452.15% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 6.42%. The 2025 estimates are for PDS Biotechnology Corporation earnings to increase by 17.15%, but the outlook for the next 5-year period is at 6.45% per year.
PDSB Dividends
PDS Biotechnology Corporation is expected to release its next quarterly earnings report in June.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 1.3271% or 0.49 million shares worth $1.43 million as of 2024-06-30.
